Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Febrile Neutropenia 7Neoplasms 5Neutropenia 2Hematologic Neoplasms 2Fever 2Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Emergencies 1

Interventions

Cyclophosphamide 58fludarabine phosphate 53Mycophenolic Acid 36Whole-Body Irradiation 35Peripheral Blood Stem Cell Transplantation 35Busulfan 33Cyclosporine 32Antilymphocyte Serum 27Tacrolimus 26Melphalan 25Filgrastim 22Cord Blood Stem Cell Transplantation 21fludarabine 20Radiotherapy 20Methotrexate 16Methylprednisolone 15Thiotepa 12Etoposide 11Cytarabine 11Granulocyte Colony-Stimulating Factor 7Cyclosporins 7Rituximab 6thymoglobulin 5Sirolimus 5Leucovorin 4Bortezomib 4Bone Marrow Transplantation 4sargramostim 3merphos 3Vorinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Meropenem × Classical hematology × Clear all
NCT05784844 2024-09-19

Antimicrobial Revision in Persistent Febrile Neutropenia

Wake Forest University Health Sciences

Phase 4 Withdrawn
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡